imipramine has been researched along with Hyperkalemia in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gould, RJ | 1 |
| Steeg, CN | 1 |
| Eastwood, AB | 1 |
| Penn, AS | 1 |
| Rowland, LP | 1 |
| De Vivo, DC | 1 |
1 other study available for imipramine and Hyperkalemia
| Article | Year |
|---|---|
Potentially fatal cardiac dysrhythmia and hyperkalemic periodic paralysis.
Topics: Arrhythmias, Cardiac; Biopsy; Child; Electromyography; Humans; Hyperkalemia; Imipramine; Male; Muscl | 1985 |